STAA
Staar Surgical Company (STAA)
Healthcare • NASDAQ • $26.69-2.16%
- Symbol
- STAA
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Price
- $26.69
- Daily Change
- -2.16%
- Market Cap
- $1.33B
- Trailing P/E
- N/A
- Forward P/E
- 34.66
- 52W High
- $30.81
- 52W Low
- $15.59
- Analyst Target
- $21.11
- Dividend Yield
- N/A
- Beta
- 1.20
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as we…
Company websiteResearch STAA on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.